novo nordisk semaglutide alzheimer trial says semaglutide, the drug used in Wegovy and Ozempic, does not slow Alzheimer's progression, despite early real-world signals that prompted two major Evoke trials involving more than 3,800 participants aged semaglutide alzheimer's study GLP-1 Drug
Pay in 4 interest-free payments of $7.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22











:max_bytes(150000):strip_icc()/VWH-GettyImages-2170138295-1e664f5616224ea39b5ba836a469d10b.jpg)











